TenX Keane Acquisition signs definitive merger with Citius Oncology; $675M equity value

CITIUS ONCOLOGY, INC.

Deal values Citius Oncology at $675M; Citius Pharma receives 67.5M shares at $10/share.
Citius Pharma to retain ~90% majority ownership in publicly listed New Citius Oncology post-close.
Transaction expected to close first half 2024, subject to shareholder and regulatory approvals.
TenX to domesticate from Cayman Islands to Delaware and rename to Citius Oncology, Inc.
Sponsor 10XYZ Holdings agrees to support deal and waive redemption rights.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CITIUS ONCOLOGY, INC. entered into Agreement and Plan of Merger and Reorganization with TenX Keane Acquisition, TenX Merger Sub, Inc., Citius Pharmaceuticals, Inc. (effective 2023-10-23).

Action: entry
Agreement: merger
Counterparty: TenX Keane Acquisition, TenX Merger Sub, Inc., Citius Pharmaceuticals, Inc.
Effective: 2023-10-23

Exact text from the filing

On October 23, 2023, TenX Keane Acquisition, a Cayman Islands exempted company (“ TenX ”), entered into an Agreement and Plan of Merger and Reorganization (the “ Merger Agreement” ), by and among TenX, TenX Merger Sub, Inc., a Delaware corporation and wholly owned Subsidiary of TenX (“ Merger Sub ”), Citius Pharmaceuticals, Inc., a Nevada corporation (“ Citius Pharma ”), and Citius Oncology, Inc., a Delaware corporation and wholly owned subsidiary of Citius Pharma (“ Citius Oncology ”).

View on SEC.gov

23 material agreements filed in the last 30 days. Browse all material agreements →

CITIUS ONCOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-038045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.